Showing results (1631-1640 of 5,643) with videos related to
Sort By:
Pageof 565
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 20, 2022
Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of HypofractionationJ Gough, W Hall, J Good, et al.The American Journal of Managed Care|February 24, 2001
Therapeutic substitution of cimetidine for nizatidine was not associated with an increase in healthcare utilizationC B Good, S L Fultz, L Trilli, et al.The Journal of Pediatrics|January 1, 1986
Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopeniaD Engelhard, J L Waner, N Kapoor, et al.Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 20, 2011
Responses to procedural information about colorectal cancer screening using faecal occult blood testing: the role of consideration of future consequencesChristian von Wagner, Anna Good, Samuel G Smith, et al.Journal of Oncology Practice|May 2, 2012
Engaging referring physicians in the clinical trial processAllison R Baer, Margo Michaels, Marjorie J Good, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Experimental approaches to nutrition and cancer: fats, calories, vitamins and mineralsR A Good, E Lorenz, R Engelman, et al.Medical Teacher|March 30, 2012
Teaching about medically unexplained symptoms at medical schools in the United KingdomMary Howman, Kate Walters, Joe Rosenthal, et al.Oncogene|February 18, 1999
Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulationE W Harhaj, L Good, G Xiao, et al.Veterinary Parasitology|January 18, 2006
Texel sheep are more resistant to natural nematode challenge than Suffolk sheep based on faecal egg count and nematode burdenB Good, J P Hanrahan, B A Crowley, et al.Osteoarthritis and Cartilage|October 27, 2004
Responsiveness of the electronic touch screen WOMAC 3.1 OA Index in a short term clinical trial with rofecoxibR Theiler, H A Bischoff-Ferrari, M Good, et al.Pageof 565